Latest news in 2024: How much does a box of venetoclax/venetoclax tablets cost?

The U.S. Food and Drug Administration (FDA approval of venetoclax for the treatment of patients with 17p deletion chronic lymphocytic leukemia (CLL) who have been previously treated with at least one other therapy was subsequently expanded to patients with CLL or small lymphocytic lymphoma (SLL), regardless of 17p deletion, who have received at least one prior therapy. In 2018, the FDA approved venetoclax in combination with azacitidine or decitabine or low-dose cytarabine (LDAC) for the treatment of newly diagnosed acute myeloid leukemia in patients 75 years of age or older and for the treatment of patients with comorbidities who are not indicated for intensive induction chemotherapy. In May 2019, the treatment was expanded to all adult patients with CLL or SLL.

The original drug of Venacla is already on the market in China. Common specifications include10mg*14 tablets, 50mg*7 tablets, 100mg*14 tablets, and 100mg*4 tablets*7 plates. The price per box may range from 1,000 to 4,000 yuan. This drug has also been included in the Class B medical insurance, but it is only reimbursed for patients who meet the criteria for adult acute myeloid leukemia.

The specifications of the Turkish version of the original drug currently sold overseasThe price of each box of 100mg*112 tablets is more than 10,000 yuan (the price may fluctuate due to the exchange rate). Generic drugs of Venacla are also sold overseas. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the specifications produced by Laos Pharmaceutical Factory100mg*120 tablets per box are about 2,000 yuan (the price may fluctuate due to the exchange rate), and the price is cheaper than the original drugs.